Tuberculous meningitis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 3, 2000, Pages 289-299

  Thwaites, G ^a,b   Chau, T T H ^b   Mai, N T H ^b   Drobniewski, F ^c   McAdam, K ^d   Farrar, J ^b,e  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Centre for Tropical Diseases Vietnam   (Viet Nam)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; AMINOSALICYLIC ACID; AMOXICILLIN; ANTIBODY; ANTIGEN; BACTERIAL VACCINE; BCG VACCINE; CEFTRIAXONE; CORTICOSTEROID; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; METRONIDAZOLE; PREDNISOLONE; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TOBRAMYCIN; TUBERCULOSTATIC AGENT;

BACTERIUM IDENTIFICATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESEARCH; ENZYME ASSAY; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NEPHROTOXICITY; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; OTOTOXICITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SERODIAGNOSIS; TUBERCULOUS MENINGITIS; VOMITING;

HUMANS; TUBERCULOSIS, MENINGEAL;

EID: 0034060836     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.3.289     Document Type: Review

References (123)

1. World Health Organisation. The world health report. Geneva: WHO, 1998.
2. LS Farer, LM Lowell, MP Meador. Extrapulmonary tuberculosis in the United States. Am J Epidemiology 1979;109: 205-17.
3. LE Davis, KR Rastogi, LC Lambert, et al. Tuberculous meningitis in the Southwest United States: a community based study. Neurology 1993;43:1775-8.
4. H Pablos-Mendez, J Blustein, CA Knirsch. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997;87:574-9.
5. MA Mori, G Leonardson, TK Welty. The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Ogala Sioux Indians. Arch Intern Med 1992;152: 547-50.
6. PA Selwyn, D Haitel, VA Lewis, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:345-50.
7. E Bishburg, G Sunderam, LB Reichman, et al Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 1986;105:210-13.
8. KM De Cock, B Soro, IM Coulibaly, et al. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992;268: 1581-7.
9. PM Small, PC Hopevvell, SP Singh, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.
10. D Alland, GE Kalkut, AR Moss, et al. Transmission of tuberculosis in New York City: an analysis by DNA finger-printing and conventional epidemiological methods. N Engl J Med 1994;330:1710-6.
11. BR Bloom, PM Small, The evolving relation between humans and Mycobacterium tuberculosis. N Engl J Med 1998;338:677-8.
12. W Stead, J Senner, W Reddick, et al. Racial differences in susceptibility to infection by mycobacterium tuberculosis. N Engl J Med 1990;322:422-7.
13. R Bellamy, C Ruwende, T Corrah, et al. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-4.
14. GA Colditz, TF Brewer, CS Berkley, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994;271: 698-702.
15. P De March-Ayuela. Trend in tuberculous meningitis in Barcelona in children 0-4 years: correlation with the annual risk of tuberculosis infection. Tuber Lung Dis 1994; 75:423-8.
16. MC Raviglione, D Snider, A Kochi. Global epidemiology of tuberculosis. Morbidity and mortality of a woldwide epidemic. JAMA 1995;273:220-6.
17. FA Drobniewski, A Pablos-Mendes, M Raviglione. Epidemiology of tuberculosis in the world. Seminars in Respiratory Critical Care Medicine 1997;18:419-29.
18. PH Green. Tubercular meningitis. Lancet 1836;ii:232-5.
19. R Koch. Die aetiologie der Tuberculosos. Ber Klin Wochenschr 1882:19:2211.
20. PA Jenkins. The microbiology of tuberculosis. In: PDO Davies, ed. Clinical tuberculosis. London: Chapman and Hall Medical. 1994.
21. BR Bloom, PM Small. The evolving relationship between humans and Mycobacterium tuberculosis. N Engl J Med 1998;10:677-8.
22. DM Collins, RP Kawakami, GW De Lisle, et al. Mutation of the principal sigma factor causes loss of virulence in a strain of mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 1995;92:8036-10.
23. SE Valway, MPC Sanchez, TF Shinnick, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1988;338:633-9.
24. Z Arvanitakis, RL Long, ES Hershfield, et al. Mycobacterium tuberculosis moleculer variation in CNS infection. Evidence for strain-dependent neurovirulence. Neurology 1998;50:1827-32.
25. S Falcow. Molecular Koch's postulates applied to microbial pathogencity. Reviews of Infectious Diseases 1988;10:S274-6.
26. DM Collins, In search of tuberculosis virulence genes. Trends Microbiol 1996;4:426-430.
27. ST Cole, R Brosch, J Parkhill, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
28. AR Rich, HA McCordick. The pathogenesis of tuberculous meningitis. Bulletin of John Hopkins Hospital 1933;52:5-37.
29. EM Lincoln, SUR Sordillo, PA Davies. Tuberculous meningitis in children. J Paediatr 1960;57:807-23.
30. DK Dastur, DK Manghani, PM Udani. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am 1995;33:733-52.
31. FY Hsieh, LG Chia, WC Shen. Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology 1992; 34:197-9.
32. DK Dastur, PM Udani. Pathology and pathogenesis of tuberculous encephalopathy. Acta Neuropathol 1966;6:311-26.
33. PM Udani, PK Dastur. Tuberculous encephalopathy with and without meningitis: clinical features and pathological correlations. J Neurol Sci 1970;10:541-61.
34. AM Dannenberg. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 1991;12:228-33.
35. MB Lurie. Resistance to tuberculosis: experimental studies in native and acquired defensive echanisms. Cambridge, MA: Harvard University Press, 1964.
36. V Kinder, AP Sappino, GE Grau, et al. The inducing role of tumour necrosis factor in the development of bacteriacidal granulomas during BCG infection. Cell 1989;56:731-10.
37. IM Orme. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol 1998;6:94-7.
38. MK Sharief, M Ciardi, EJ Thompson. Blood brain barrier damage in patients with bacterial meningitis: association with tumour necrosis factor α but not interleukin-1 β. J Infect Dis 1992;166:350-8.
39. EA Filley, GA Rook. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumour necrosis factor. Infect Immunol 1991;59:2567-72.
40. L Tsenova, K Sokol, V Freedman, et al. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis 1998; 177:1563-72.
41. GAW Rook, R Al Attiyah. Cytokines and the Koch phenomena. Tubercle 1991;72:13-20.
42. M Parsons. Tuberculous meningitis. A handbook for clinicians. Oxford: Oxford University Press, 1979.
43. RS Illingworth. Miliary and meningeal tuberculosis. Lancet 1956;ii:646-9.
44. SJ Kent, SM Crowe, A Yung, et al. Tuberculous meningitis: a 30 year review. Clin Infect Dis 1993;17:987-94.
45. R Verdon, S Chevret, JP Laissy, et al. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 1996;22:982-8.
46. J Berenguer, S Moreno, F Laguna, et al. Tuberculous meningitis in patients with human immunodeficiency virus. N Engl J Med 1992;326:668-72.
47. MP Dube, PD Holtom, RA Larsen, Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992;93:520-4.
48. VK Yechopr, WX Shandera, P Rodriguez, et al. Tuberculous meningitis among adults with and without HIV infection. Arch Int Med 1996;156:1710-16.
49. AS Karstaedt, S Valtchanova, R Barriere, et al. Tuberculous meningitis in South African urban adults. Q J Med 1988;91:743-7.
50. J Leonard, RM Des Prez. Tuberculous meningitis. Infect Dis Clin North Am 1990;4:769-87.
51. PR Donald, JF Schoeman, LE Van Zyl, et al. Intensive short course chemotherapy in the mangement of tuberculous meningitis. International Journal of Tuberculosis and Lung Diseases 1998;2:704-11.
52. MJ Humphries, WK Lam, R Teoh. Non-respiratory tuberculosis. In: PDO Davies, ed. Clinical tuberculosis. London: Chapman and Hall Medical 1994.
53. T Tartaglione, GM Di Lella, A Cesare, et al. Diagnostic imaging of neurotuberculosis. Rays 1998;23:164-80.
54. PD Gulati, GP Mathur, H Vaishnavah. Prognosis and sequelae of tuberculous meningitis in adults. J Assoc Physicians India 1970;18:281-6.
55. Medical Research Council. Streptomycin in tuberculous trials committee. Streptomycin treatment of tuberculous meningitis. Lancet 1948;i:582-97.
56. MJ Humphries, R Teoh, J Lau, et al. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle 1990;71;161-8.
57. UK Misra, J Kalita, M Srivastava, et al. Prognosis of tuberculous meningitis: a multivariate analysis. J Neurol Sci 1996;137:57-61.
58. HV Smith, RL Vollum. The diagnosis of tuberculous meningitis. Br Med Bull 1954;10:140-4.
59. T Jeren, I Beus. Characteristics of cerebrospinal fluid in tuberculous meningitis. Acta Cytol 1982;26:678-80.
60. DH Kennedy, RJ Fallon. Tuberculous meningitis. JAMA 1979;241:264-8.
61. PC Hopewell. Overview of clinical tuberculosis. In: BR Bloom, Tuberculosis: pathogenesis, protection, and control. Washington, DC: ASM, 1994.
62. SH Gillespie, TD McHugh. The genus Mycobacterium. In, AM Emmerson, PM Hawkey, SH Gillespie, eds. Principles and practice of clinical bacteriology. Chichester: John Wiley, 1997.
63. S Bhargava, AK Gupta, PN Tandon. Tuberculous meningitis: a CT study. Br J Radiol 1982;55:189-96.
64. MRR Bullock, JM Welchman. Diagnostic and prognostic features of tuberculous meningitis on CT scanning. J Neurol Neurosurg Psychiatry 1982;45:1098-101.
65. PA Mardh, L Larsson, N Holby, et al. Tuberculostearic acid as a diagnositic marker in tuberculous meningitis. Lancet 1983;i:367.
66. JB Brooks, MI Daneshvar, RL Haberberger, et al. Rapid diagnosis of tuberculous meningitis by frequency-pulsed electron-capture gas-liquid chromatography detection of carboxylic acids in cerebrospinal fluid. J Clin Microbiol 1990;28:989-97.
67. E Ribera, JM Martinez-Vazquez, I Ocana, et al. Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults. J Infect Dis 1987;155:603-7.
68. LF Lopez-Cortes, M Cruz-Ruiz, J Gomez-Mateos, et al. Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis. Clin Infect Dis 1995;20: 525-30.
69. SB Kalish, RC Radin, D Levitz, et al. The enzyme-linked immunosorbent assay method for IgG antibody to purified protein derivative in cerebrospinal fluid of patients with tuberculous meningitis. Ann Intern Med 1983;99:630-3.
70. G Watt, G Zaraspe, S Bautista, et al. Rapid diagnosis of tuberculous meningitis by using an enzyme-linked immunosorbent assay to detect mycobacterial antigen and antibody in cerebrospinal fluid. J Infect Dis 1988;158:681-6.
71. EGL Wilkins, J Ivanyi. Potential value of serology for diagnosis of extrapulmonary tuberculosis. Lancet 1990;336: 641-4.
72. C-Z Lu, J Qiao, T Shen, et al. Early detection of tuberculous meningitis by detection of anti-BCG secreting cells in cerebrospinal fluid. Lancet 1990;336:10-13.
73. SM Baig. Anti-purified protein derivative cell-enzyme-linked immunosorbent assay, a sensitive method for the early diagnosis of tuberculous meningitis. J Clin Microbiol 1995;33:3040-1.
74. E Sada, GM Ruiz-Palacios, Y Lopez-Vidal, et al. Detection of mycobacterial antigens in cerebrospinal fluid of patients with tuberculous meningitis by immunosorbent assay. Lancer 1983;ii:651-2.
75. GV Kadival, TB Mazarelo, SD Chaparas. Sensitivity and specificity of enzyme-linked immunosorbent assay in the detection of antigen in tuberculous meningitis cerebrospinal fluids. J Clin Microbiol 1986;23:901-1.
76. E Krambovitis, MB McIlmurray, PE Lock, et al. Rapid diagnosis of tuberculous meningitis by latex particle agglutination. Lancet 1984;ii:1229-31.
77. VV Radhakrishnan, S Sehgal, A Mathai. Correlation between culture of Mycobacterium tuberculosis and detection of mycobacterial antigens in cerbrospinal fluid of patients with tuberculous meningitis. J Med Microbiology 1990;33:223-6.
78. A Mathai, V.V Radhakrishnan, S Shobha. Diagnosis of tuberculous meningitis confirmed by means of an immunoblot method. J Infect 1994;29:33-9.
79. GK Ahuja, KK Mohan, K Prasad, et al. Diagnostic criteria for tuberculous meningitis and their validation. Tuber Lung Dis 1994;75:149-52.
80. P Shankar, N Manjunath, KK Mohan, et al. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 1991;337:5-7.
81. LFF Kox, S Kuijper, AHJ Kolk. Early diagnosis of tuberculous meningtitis by polymerase chain reaction. Neurology 1995;45:2228-32.
82. A Bonington, JI Strang, PE Klapper, et al. Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis. J Clin Microbiol 1998; 36:1251-4.
83. LN Nguyen, LFF Kox, D Linh, et al. The potential contribution of polymerase chain reaction to the diagnosis of tuberculous meningitis. Arch Neurol 1996;53:771-6.
84. JJ Lin, HJ Harn. Application of polymerase chain reaction to monitor Mycobacterium tuberculosis DNA in the CSF of patients with tuberculous meningitis after antibiotic treatment. J Neurol Neurosurg Psychiatry 1995;242:147-52.
85. RF D'Amato, AA Wallman, LH Hochstein, et al. Rapid diagnosis of pulmonary tuberculosis by using Roch AMPLICOR Mycobacterium tuberculosis PCR test. J Clin Microbiol 1995;33:1832-4.
86. AM Lang, J Feris-Iglesias, C Pena, et al. Clinical evaluation of the Gen-Probe amplified direct test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol 1998;36:2191-4.
87. RTD Emond, GSW McKendrick. Tuberculosis as a cause of transient aseptic meningitis. Lancet 1973;ii:234-6.
88. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53:536-48.
89. J Lorber. Treatment of tuberculous meningitis. BMJ 1960;i: 1309-12.
90. P Ramachandran, M Duraipandian, M Nagarajan, et al. Three chemotherapy studies of tuberculous meningitis in children. Tubercle 1986;67:17-29.
91. P Ramachandran, M Duraipandian, AM Reetha, et al. Long-term status of children treated for tuberculous meningitis in South India. Tubercle 1989;70:17-29.
92. GA Ellard, MJ Humphries, BW Allen. Cerbrospinal fluid drug concentrations and treatment of tuberculous meningitis. Am Rev Respir Dis 1993;148:650-5.
93. R Nau, HW Prange, S Menck, et al. Penetration of rifampicin into CSF of adults with uninflamed meninges. J Antimicrob Chemother 1992;29:719-24.
94. R Forgan-Smith, G Ellard, D Newton, et al. Pyrazinamide and other drugs in tuberculous meningitis. Lancet 1973:ii: 374.
95. M Humphries. The management of tuberculous meningitis. Thorax 1992;47:577-81.
96. DH Heilman, FR Heilman, HK Hinshaw, et al. Streptomycin: absorption, diffusion, excretion, and toxicity. Am J Med Sci 1945;210:567-82.
97. PR Donald, HI Seifart. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Paeds 1989;115:483-6.
98. A Goel, S Pandya, A Satoskar. Whither short-course chemotherapy for tubercuous meningitis. Neurosurgery 1990;27:418-21.
99. EL Kendig, CD Burch. Short-term antimicrobial therapy of tuberculous meningitis. Am Rev Respir Dis 1960;82:672-81.
100. RF Jacobs, P Sunakorn, T Chotpitayasunonah, et al. Intensive short course chemotherapy for tuberculous meningitis. Paediatric Infectious Disease Journal 1992;11:194-8.
101. P Phuapradit, A Vejjajiva. Treatment of tuberculous meningitis: role of short-course chemotherapy. Q J Med 1987;62:249-58.
102. PR Donald, JF Schoeman, N Beyers. Concentrations of interferon γ, tumour necrosis factor a, and interleukin-1 β in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis 1995;21:924-9.
103. D Dooley, JL Carpenter, S Rademacher. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997;25:872-87.
104. M Ashby, H Grant. Tuberculous meningitis treated with cortisone. Lancet 1955;i:65-6.
105. J Escobar, MA Belsey, A Duenas, et al. Mortality from tuberculous meningitis reduced by steroid therapy. Paediatrics 1975;56:1050-5.
106. NI Girgis, Z Farid, ME Kilpatrick, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Paediatric Injections Disease Journal 1991;10:179-83.
107. JM Leonard, RM Prez. Tuberculous meningitis. Infect Dis Clin North Am 1990;4:769-87.
108. JF Schoeman, LE Van Zyl, JA Laubscher, et al. Effect of corticosteroids on intracranial pressure, computed tomographic findings and clinical outcome in young children with tuberculous meningitis. Paediatrics 1997;99:226-31.
109. S Kaojarern, K Supmonchai, P Phuapradit, et al. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacother 1991;49:6-12.
110. PK Newman, WJK Cumming, JB Foster. Hydrocephalus and tuberculous meningitis in adults. J Neurol Neurosurg Psychiatry 1980;43:188-90.
111. R Palur, V Rajshekhar, MJ Chandy, et al. Shunt surgery for hydrocephalus in tuberculous meningitis: a long term follow up study. J Neurosurg 1991;74:64-9.
112. B Afghani, JM Lieberman. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994;19:1092-9.
113. BG Marshall, MA Chambers. Central nervous system tuberculosis: the paradox of the host immune response. J Infect 1998;36:3-4.
114. PH Tandin, S Bhargaga. Effect of medical treatment in intracranial tuberculoma: a CT study. Tubercle 1985;66:85.
115. AD Lein, CF Von Reyn. In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculous infection and assessment of response to mycobacterial vaccines. Am J Med Sci 1997;313:364-71.
116. PR Wood, JS Rothel. In vitro immunodiagnostic assays for bovine tuberculosis. Vet Microbiol 1994;40:125-35.
117. GL Mukamolova, AS Kaprelyants, DI Young, et al. A bacterial cytokine. Proc Natl Acad Sci USA 1998;95:8916-21.
118. WR Jacobs, RG Barletta, R Udani. Rapid assessment of drug susceptibilities of MTB by means of luciferase reporter phages. Science 1993;260:819-22.
119. FA Drobniewski, SM Wilson. The rapid diagnosis of isoniazid and rifampicin drug resistance in Mycobacterium tuberculosis: a molecular story. J Med Microbiol 1997;47: 189-96.
120. C Carriere, PF Riska, O Zimhony, et al. Conditionally replicating reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of mycobacterium tuberculosis. J Clin Microbiol 1997;35:3232-9.
121. SM Wilson, Z Al-Suwaidi, R McNerney, et al. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med 1997;3:465-8.
122. IJ Eltringham, FA Drobniewski, JA Mangan, et al. Evaluation of RT-PCR and a bacteriphage based assay for the rapid phenotypic detection of rifampicin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999;37:3524-7.
123. IJ Eltringham, SM Wilson, FA Drobniewski. Evaluation of a bacteriophage based assay (Phab assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999;37: 3528-32.